Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
Byung Soo Kwan, Jeong Han Kim, Seong Jun Park, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo
Korean J Intern Med. 2021;36(2):292-304. Published online 2020 Apr 3 DOI: https://doi.org/10.3904/kjim.2019.297
Citations to this article as recorded by 
Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study
Bo Ram Sung, Sang Goon Shim, Kwang Min Kim, Jung Won Lee, Jun Young Kim, Bo Kyeong Lee, Cheon Hoo Jun, Byung Soo Kwan
Medicine.2025; 104(50): e46449. CrossRef
Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
Won Sohn
The Korean Journal of Internal Medicine.2021; 36(2): 286. CrossRef